Cabadés A, López-Bescós L, Arós F, Loma-Osorio A, Bosch X, Pabón P, Marrugat J
Unidad Coronaria, Hospital La Fe, Valencia.
Rev Esp Cardiol. 1999 Oct;52(10):767-75. doi: 10.1016/s0300-8932(99)75004-9.
The paucity of data on myocardial infarction management and results in Spain lead to the design of the PRIAMHO study (Proyecto de Registro de Infarto Agudo de Miocardio Hospitalario [Acute Myocardial Infarction Hospital Registration Project]) which developed standard methods to collect information on the management of patients with such a condition and their characteristics. The variability results among hospitals in myocardial infarction management and in one-year mortality are presented.
A cohort study with a one-year follow-up was designed to register all patients diagnosed with acute myocardial infarction discharged from 24 Spanish hospitals that completed all the requisites to participate. The demographic and clinical characteristics of the patients, their management during the coronary care unit stage, and the outcome and complications were prospectively registered. Standard definitions for diagnosis were used. Confidentiality regarding patient identity and participating centers was guaranteed.
5,242 (77.6%) of the 6,756 patients with myocardial infarction admitted in the 24 participating hospitals were registered in the coronary care units. Half of the centers had an on-site hemodynamic laboratory and in seven coronary surgery. The delay between symptom-onset and emergency room admission was 2 hours. Acute pulmonary edema or cardiogenic shock was developed by 16.6% of patients and 41.8% received thrombolysis. Mean time delay between symptom-onset and thrombolysis was 3 hours. A large variability in the use of beta-blockers, thrombolysis, echocardiography, coronary catheterization angiography and invasive revascularization was observed among hospitals. Mortality in the coronary care unit was 10.9% and increased to 14.0% at 28 days and to 18.5% at one year with considerable variation among hospitals. Four hospitals showed higher mortality among their patients, independently from the proportion of diabetes, hypertension, women, anterior location of myocardial infarction, non-Q-wave infarction, age and severity.
The results of this study show that early and mid-term mortality from myocardial infarction is still high in Spain in the reperfusion era, and that a considerable variability in management and outcome exists among Spanish hospitals, which is not explained by the different case-mix among them.
西班牙关于心肌梗死治疗及结果的数据匮乏,由此促成了PRIAMHO研究(急性心肌梗死医院登记项目)的开展,该研究制定了标准方法来收集此类疾病患者的治疗及特征信息。本文呈现了各医院在心肌梗死治疗及一年死亡率方面的差异结果。
设计了一项为期一年随访的队列研究,对从24家完成所有参与条件的西班牙医院出院的所有诊断为急性心肌梗死的患者进行登记。前瞻性地记录患者的人口统计学和临床特征、在冠心病监护病房阶段的治疗情况以及结局和并发症。采用标准的诊断定义。确保了患者身份和参与中心的保密性。
24家参与医院收治的6756例心肌梗死患者中,有5242例(77.6%)被登记到冠心病监护病房。一半的中心设有现场血流动力学实验室,7家有冠状动脉外科。症状发作至急诊室就诊的延迟时间为2小时。16.6%的患者发生急性肺水肿或心源性休克,41.8%的患者接受了溶栓治疗。症状发作至溶栓的平均延迟时间为3小时。各医院在β受体阻滞剂、溶栓、超声心动图、冠状动脉导管造影和有创血运重建的使用方面存在很大差异。冠心病监护病房的死亡率为10.9%,28天时升至14.0%,一年时升至18.5%,各医院之间存在显著差异。四家医院的患者死亡率较高,与糖尿病、高血压、女性、心肌梗死前壁位置、非Q波梗死、年龄和严重程度的比例无关。
本研究结果表明,在西班牙,再灌注时代心肌梗死的早期和中期死亡率仍然很高,而且西班牙各医院在治疗和结局方面存在相当大的差异,这无法用它们不同的病例组合来解释。